|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 438.95 DKK | -3.64% |
|
-2.74% | -29.68% |
| 07-11 | European stocks down with bank and healthcare drag, US-EU tariffs in focus | RE |
| 07-11 | FDA May Fast Track Drug Reviews for Lower US Prices | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Other Pharmaceuticals
| Capi. | Sales growth | Profitability (Composite) | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
| 317B | ||||||
| 710B | ||||||
| 379B | ||||||
| 344B | ||||||
| 265B | ||||||
| 244B |
- Stock Market
- Equities
- NOVO B Stock
- Charts Novo Nordisk A/S
- Sector Chart
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition